Vitenskap BIOGEN IDEC ANNOUNCES OFFICIAL PARTNERSHIP WITH SAILING SCLEROSIS? ?OCEANS OF HOPE? TO GLOBALLY CHANGE PERCEPTIONS OF MS 28 mai 201415 desember 2019y6.no
Vitenskap CHMP ADOPTS POSITIVE OPINION FOR PLEGRIDYTM (PEGINTERFERON BETA-1A) AS A TREATMENT FOR MULTIPLE SCLEROSIS IN THE EUROPEAN UNION 28 mai 201415 desember 2019y6.no
Teknologi CHMP DETERMINES DIMETHYL FUMARATE IN TECFIDERA? TO BE A NEW ACTIVE SUBSTANCE IN THE EUROPEAN UNION 25 november 201315 desember 2019y6.no
Milj? BIOGEN IDEC AND ELAN SUBMIT APPLICATIONS FOR FIRST-LINE USE OF TYSABRI IN ANTI-JCV ANTIBODY NEGATIVE PATIENTS WITH MS 17 januar 201315 desember 2019y6.no
